Prostate Cancer News on BioPortfolio

Northwest Biotherapeutics Announces Registered Direct Offering

BETHESDA Md. Aug. 9 2013 PRNewswire &160;Northwest Biotherapeutics NASDAQ NWBO NW Bio a biotechnology company developing DCVax&174; personalized immune therapies for solid tumor cancers announced today that on August 8 2013 it entered into an agree...

Inovio Pharmaceuticals Responds to Market Activity

BLUE BELL Pa. Aug. 6 2013 PRNewswire &160;Inovio Pharmaceuticals Inc. NYSE MKT INO announced today that in view of the unusual market activity in the company's stock the Exchange has contacted the company in accordance with its usual practice. The comp...

Angle AGL A boost for prostate cancer indication

Edison Investment Research Pharmaceutical & healthcare Angle Yesterday Angle announced that researchers from Queen Mary University of London&039;s Barts Cancer Institute BCI published new data further supporting Angle’s Parsortix system...

Prostate CancerAPI Insights 2017 Updated 30052017 Prices from USD $1063

The active pharmaceutical ingredients worldwide market is in continuous development from the recent years. There is expected to be a major impact on the global API industry with the large number of blockbuster drugs going off patent in the coming years. It...

Advaxis to Present at 2017 BIO International Convention

Advaxis Inc. NASDAQ ADXS a latestage biotechnology company developing cancer immunotherapies today announced that Ranya Dajani Vice President Business Development will present a company overview at the

Cancer TestingScreening Market By TechniquesBiomarker Test PSA CTC AFP Tests; By Imaging MRI Scan CT Scan By Technologies NGS QPCR IHC Applications Geography Forecasts 2016 2021. Updated 15032016 Prices from USD $5250

Cancer is a group of diseases which involves the abnormal cell growth with the ability or the potential to spread to the other parts of the body. These cells form a neoplasm where neoplasm or tumor is a group of cells that will undergo an unregulated growt...

Pages